Robert S Wilson1, Jingyun Yang2, Lei Yu2, Sue E Leurgans2, Ana W Capuano2, Julie A Schneider2, David A Bennett2, Patricia A Boyle2. 1. From the Departments of Neurological Sciences (R.S.W., J.Y., L.Y., S.E.L., A.W.C., J.A.S., D.A.B.), Behavioral Sciences (R.S.W., P.A.B.), and Pathology (J.A.S.), Rush University Medical Center, Rush Alzheimer's Disease Center, Chicago, IL. rwilson@rush.edu. 2. From the Departments of Neurological Sciences (R.S.W., J.Y., L.Y., S.E.L., A.W.C., J.A.S., D.A.B.), Behavioral Sciences (R.S.W., P.A.B.), and Pathology (J.A.S.), Rush University Medical Center, Rush Alzheimer's Disease Center, Chicago, IL.
Abstract
OBJECTIVE: To assess whether neurodegenerative pathologies are differentially related to trajectories of change in different cognitive abilities. METHODS: At annual intervals for up to 21 years, 915 older participants in a longitudinal clinical-pathologic cohort study completed a battery of 15 tests from which previously established composite measures of episodic memory, semantic memory, working memory, and perceptual speed were derived. At death, they underwent a neuropathologic examination to quantify Alzheimer disease pathology, Lewy bodies, transactive response DNA-binding protein 43 (TDP-43) pathology, and hippocampal sclerosis plus multiple markers of cerebrovascular disease. Time-varying effect models were used to assess change over time in the relation of neuropathologic markers to cognitive trajectories. RESULTS: Controlling for pathology, decline in perceptual speed was evident about 15 years before death; modest decline in semantic and working memory occurred later; and there was little change in episodic memory. Each neurodegenerative marker was associated with lower episodic memory function beginning about 10 to 16 years before death. As time before death decreased, Alzheimer disease pathology, Lewy bodies, and hippocampal sclerosis were associated with impairment in other cognitive domains but the association of TDP-43 pathology with cognition continued to be mainly confined to episodic memory. CONCLUSIONS: The results suggest that episodic memory impairment is an early sign of multiple neurodegenerative conditions, which primarily differ in their associations with other cognitive systems.
OBJECTIVE: To assess whether neurodegenerative pathologies are differentially related to trajectories of change in different cognitive abilities. METHODS: At annual intervals for up to 21 years, 915 older participants in a longitudinal clinical-pathologic cohort study completed a battery of 15 tests from which previously established composite measures of episodic memory, semantic memory, working memory, and perceptual speed were derived. At death, they underwent a neuropathologic examination to quantify Alzheimer disease pathology, Lewy bodies, transactive response DNA-binding protein 43 (TDP-43) pathology, and hippocampal sclerosis plus multiple markers of cerebrovascular disease. Time-varying effect models were used to assess change over time in the relation of neuropathologic markers to cognitive trajectories. RESULTS: Controlling for pathology, decline in perceptual speed was evident about 15 years before death; modest decline in semantic and working memory occurred later; and there was little change in episodic memory. Each neurodegenerative marker was associated with lower episodic memory function beginning about 10 to 16 years before death. As time before death decreased, Alzheimer disease pathology, Lewy bodies, and hippocampal sclerosis were associated with impairment in other cognitive domains but the association of TDP-43 pathology with cognition continued to be mainly confined to episodic memory. CONCLUSIONS: The results suggest that episodic memory impairment is an early sign of multiple neurodegenerative conditions, which primarily differ in their associations with other cognitive systems.
Authors: Erin L Abner; Richard J Kryscio; Frederick A Schmitt; David W Fardo; Daniela C Moga; Eseosa T Ighodaro; Gregory A Jicha; Lei Yu; Hiroko H Dodge; Chengjie Xiong; Randall L Woltjer; Julie A Schneider; Nigel J Cairns; David A Bennett; Peter T Nelson Journal: Ann Neurol Date: 2017-03-22 Impact factor: 10.422
Authors: Manuela Neumann; Linda K Kwong; Edward B Lee; Elisabeth Kremmer; Andrew Flatley; Yan Xu; Mark S Forman; Dirk Troost; Hans A Kretzschmar; John Q Trojanowski; Virginia M-Y Lee Journal: Acta Neuropathol Date: 2009-01-06 Impact factor: 17.088
Authors: Patricia A Boyle; Lei Yu; Robert S Wilson; Sue E Leurgans; Julie A Schneider; David A Bennett Journal: Ann Neurol Date: 2018-01-14 Impact factor: 10.422
Authors: Robert S Wilson; Lei Yu; John Q Trojanowski; Er-Yun Chen; Patricia A Boyle; David A Bennett; Julie A Schneider Journal: JAMA Neurol Date: 2013-11 Impact factor: 18.302
Authors: Sukriti Nag; Lei Yu; Robert S Wilson; Er-Yun Chen; David A Bennett; Julie A Schneider Journal: Neurology Date: 2017-01-13 Impact factor: 9.910
Authors: Zoe Arvanitakis; Ana W Capuano; Sue E Leurgans; David A Bennett; Julie A Schneider Journal: Lancet Neurol Date: 2016-06-14 Impact factor: 44.182
Authors: Lei Yu; Gary Mottola; Lisa L Barnes; S Duke Han; Robert S Wilson; David A Bennett; Patricia A Boyle Journal: Gerontology Date: 2021-04-21 Impact factor: 5.597
Authors: Lei Yu; Julie A Schneider; Alifiya Kapasi; David A Bennett; Patricia A Boyle Journal: Alzheimer Dis Assoc Disord Date: 2020 Oct-Dec Impact factor: 2.357
Authors: Peter T Nelson; Dennis W Dickson; John Q Trojanowski; Clifford R Jack; Patricia A Boyle; Konstantinos Arfanakis; Rosa Rademakers; Irina Alafuzoff; Johannes Attems; Carol Brayne; Ian T S Coyle-Gilchrist; Helena C Chui; David W Fardo; Margaret E Flanagan; Glenda Halliday; Suvi R K Hokkanen; Sally Hunter; Gregory A Jicha; Yuriko Katsumata; Claudia H Kawas; C Dirk Keene; Gabor G Kovacs; Walter A Kukull; Allan I Levey; Nazanin Makkinejad; Thomas J Montine; Shigeo Murayama; Melissa E Murray; Sukriti Nag; Robert A Rissman; William W Seeley; Reisa A Sperling; Charles L White; Lei Yu; Julie A Schneider Journal: Brain Date: 2019-06-01 Impact factor: 15.255
Authors: David X Thomas; Sumali Bajaj; Kevin McRae-McKee; Christoforos Hadjichrysanthou; Roy M Anderson; John Collinge Journal: Sci Rep Date: 2020-09-03 Impact factor: 4.379
Authors: Kristina M Gicas; William G Honer; Robert S Wilson; Patricia A Boyle; Sue E Leurgans; Julie A Schneider; David A Bennett Journal: Neurology Date: 2020-11-03 Impact factor: 9.910
Authors: Caglar Cosarderelioglu; Lolita S Nidadavolu; Claudene J George; Esther S Oh; David A Bennett; Jeremy D Walston; Peter M Abadir Journal: Front Neurosci Date: 2020-09-30 Impact factor: 4.677